https://www.selleckchem.com/pr....oducts/Ilginatinib-h
This therapy is a new endogenous anti-allergic approach.OBJECTIVE To objectively evaluate the safety of acupoint catgut embedding therapy. METHODS A total of 331 patients who received acupoint catgut embedding therapy were enrolled and summarized through the inpatient medical record system, follow-up record and adverse reaction report card. The statistical analysis was performed from the aspects of patients' gender, age, marital status, history of allergy, history of diabetes and the time, symptoms, duration and progno
Gefällt mir
Kommentar
Teilen
